Home/Filings/4/0000950170-24-015545
4//SEC Filing

Emany Sravan Kumar 4

Accession 0000950170-24-015545

CIK 0001446847other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 8:39 PM ET

Size

7.0 KB

Accession

0000950170-24-015545

Insider Transaction Report

Form 4
Period: 2024-02-12
Emany Sravan Kumar
SVP, Chief Financial Officer
Transactions
  • Award

    Class A Common Stock

    2024-02-12+65,312291,049 total
  • Award

    Performance-based Restricted Stock Unit

    2024-02-12+32,65632,656 total
    Exp: 2027-02-28Class A Common Stock (32,656 underlying)
Footnotes (2)
  • [F1]The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
  • [F2]Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Documents

1 file

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001897662

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:39 PM ET
Size
7.0 KB